• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 102208-905
Device Problem Imprecision (1307)
Patient Problem Hypoglycemia (1912)
Event Date 03/04/2024
Event Type  Injury  
Manufacturer Narrative
The manufacturer is currently performing investigation and the results will be provided in the supplemental report.
 
Event Description
On march 7, 2024, senseonics was made aware of an incident where the patient complained of receiving a low glucose alert even though there was no actual hypoglycemia event.The patient reported that blood glucose (bg) value on (b)(6) 2024 at 10 am was 157 mg/dl where as sensor glucose (sg) value was 48 mg/dl.The system asserted a low glucose alert as the value went below the low glucose alert threshold which was set at 65 mg/dl.The patient had no symptoms and no actions were needed to be taken.
 
Manufacturer Narrative
The initial investigation was performed on customer synced glucose data on data management system (dms), which is a cloud platform for eversense systems.Based on initial investigation analysis, the sensor glucose (sg) value on (b)(6) 2024 at 10:02 am was 45 mg/dl and blood glucose (sg) value was not entered into the system.The customer did not seek any help as it was not a true hypoglycemia event.An overall review of the system performance did not reveal any malfunction.However, it revealed symptoms consistent with situations where estimated values provided by the app (sg values) were entered as calibrations rather than true bg values.The customer confirmed that in fact he calibrated 2 or 3 times using the app values.Customer was advised to not enter anything other than a true bg meter value as it can disrupt the calibration and lead to significant deviations in the sensor readings.No further investigation was found necessary for this complaint.B4.Date of this report updated to 19 april 2024.G3.Date received by manufacturer updated to 19 april 2024.H3.Device evaulated by manufacturer? yes.H6.Investigation findings updated to 114.H6.Investigation conclusions updated to 19.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key19048166
MDR Text Key339435853
Report Number3009862700-2024-00597
Device Sequence Number1
Product Code QHJ
UDI-Device Identifier00817491023407
UDI-Public817491023407
Combination Product (y/n)Y
Reporter Country CodeIT
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/04/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number102208-905
Device Catalogue NumberFG-3500-05-001
Device Lot Number139176
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received04/19/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/31/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-